ACMG Annual Clinical Genetics Meeting 2027 Exhibitor List

Dr. Padeganeh, PhD, FACMG, is a board-certified clinical cytogeneticist and molecular geneticist serving as a Technical Director at the Southern California Permanente Medical Group (SCPMG), Kaiser Permanente's Regional Molecular Genetic and Genomic Pathology Laboratory and a Clinical Assistant Professor at the Kaiser Permanente Bernard J. Tyson School of Medicine. He previously served as Associate Director of the Clinical Cancer Cytogenetics Laboratory at City of Hope. Having earned a PhD from the University of Montreal, Dr. Padeganeh completed ABMGG training in Clinical Cytogenetics and Molecular Genetics at the Greenwood Genetic Center and SCPMG, respectively. He holds ABMGG certifications in Clinical Cytogenetics and Laboratory Genetics and Genomics (LGG) and is licensed as a lab director in CA and NY. Dr. Padeganeh has served on the ACMG's Education and CME Committee and is currently a member of the ACMG's Advocacy and Government Affairs Committee, the American Cytogenetics Conference BOD, and the ClinGen's Hereditary Cancer Dosage Sensitivity Subgroup with an interest in advocacy, education, and leadership initiatives.

Ada Hamosh MD, MPH, the Dr. Frank V. Sutland Professor of Pediatric Genetics, is the Clinical Director of the McKusick-Nathans Department of Genetic Medicine at Johns Hopkins University School of Medicine and the Scientific Director of Online Mendelian Genetics in Man (OMIM®) since 2002. Dr. Hamosh received her BA in Biology from Wesleyan University, MD from Georgetown University, and MPH from Johns Hopkins School of Hygiene and Public Health. She completed a pediatrics residency and clinical and clinical biochemical genetics fellowships at Johns Hopkins Hospital. Dr. Hamosh has authored over 140 papers and serves on several international committees representing genome-phenome relationships as well as phenotype ontologies, including,the ClinGen Project, the Global Alliance for Genomic Health (GA4GH), and the Human Genome Organization (HUGO). She is serving a two-year term as President of HUGO since Spring 2023. She and colleagues developed PhenoDB (http://phenodb.org), a web-based tool for the collection, storage, and analysis of standardized phenotype and genotype data that is freely available to all for clinical and research use, and GeneMatcher (http://genematcher.org), a website to enable matches of clinicians and researchers with an interest in the same gene. GeneMatcher includes over 16,800 submitters from 114 countries and >96,000 cases. Matches through GeneMatcher have resulted in >930 publications describing >700 novel disease genes. GeneMatcher is a founding member of the Matchmaker Exchange (MME). Dr. Hamosh serves on the steering committee of the MME and represents it on the steering committee of the Global Alliance for Genomics and Health (GA4GH).

Adam de Smith, PhD, is an Assistant Professor in the USC Center for Genetic Epidemiology in the Department of Population and Public Health Sciences, and is a member of the USC Norris Comprehensive Cancer Center. He is a genetic epidemiologist with a research focus on identifying the causes of acute lymphoblastic leukemia (ALL), the most common childhood cancer. Dr. de Smith leads studies investigating the role of common and rare genetic variants in ALL etiology, with a particular interest in elucidating the increased ALL risk in individuals of Hispanic/Latino ethnicity. He leads a study of leukemia in children with Down syndrome, the International Study of Down Syndrome Acute Leukemia, investigating genetic and epigenetic variation associated with risk of Down syndrome ALL. He also co-leads the ReCord Study, enrolling patients with banked cord blood samples to investigate the early-life origins of childhood leukemia across molecular subtypes.

Dr. Smith is a dual-boarded Clinical Cytogeneticist and Clinical Molecular Geneticist certified by the Canadian College of Medical Geneticists (CCMG). Dr. Smith is also a fellow of the American College of Genetics and Genomics (FACMG) and a Certified Laboratory Geneticist (erCLG) by the European Board of Medical Genetics. Dr. Smith completed his Master's degree in 2000 in the Department of Laboratory Medicine and Pathobiology at the University of Toronto on the Pathomechanism of Costello syndrome. He completed his Ph.D. in the Institute of Medical Science at the University of Toronto unraveling the genetic and epigenetic mechanisms that control growth and cancer development at a locus on human chromosome 11 in the Beckwith-Wiedemann syndrome. Dr. Smith has been an international leader in the development of Optical Genome Mapping technology. He led an International Consortium for Optical Genome Mapping and was the senior author of a Framework for Optical Genome Mapping clinical use in Hematologic Malignancies.

I am a Clinical Geneticist and Director of Medical School Genetics Education for the Center for Human Genetics at University Hospitals Cleveland Medical Center. I have served as the Associate Residency Director. I have been integrally involved with and led committees for medical student and resident Genetics education at Case Western Reserve University School of Medicine and the hospital system. I am the Chair of the ACMG Education Committee and was an executive member of APHMG course directors special interest group. I am very involved in teaching medical students, genetic counselors and residents on a regular basis. I take pride in being a well-rounded General Geneticist.

Adriel Y. Kim, PhD, is a first year Laboratory Genetics and Genomics fellow at The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital. She completed her B.S. in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign and M.S. in Diagnostic Genetics from the University of Texas MD Anderson Cancer Center. She earned her Ph.D. in the Molecular Medicine program at the Lerner Research Institute of Cleveland Clinic and Case Western Reserve University. Her master's thesis involved optimizing whole genome amplification method in the development of a non-invasive prenatal test using single fetal cells from the maternal circulation. During her doctoral research, she focused on comparative genome-wide analysis of germline variants in PTEN hamartoma tumor syndrome (PHTS), a rare genetic disorder associated with cancer predisposition and autism spectrum disorder (ASD), to identify genetic modifiers and develop prediction models for cancer vs. ASD outcomes in PHTS. Additionally, she received a formal training in clinical cytogenetics at the University of Texas Health Science Center in San Antonio after her B.S. and nurtured deep passions for cytogenomic technologies by working several years in clinical laboratories. Supported by her years of clinical and translationally focused research experiences, Dr. Kim plans to commit to integrating cytogenomics and various molecular applications to deliver accurate diagnosis and facilitate improved patient care.

Aimiel Casillan is a licensed, board-certified genetic counselor at Valley Children's Healthcare with a focus in reproductive and cardiovascular genetics. She obtained her Master's of Science in Genetic Counseling at the Columbia University Vagelos College of Physicians and Surgeons. As a clinician, she provides genetic counseling to individuals with high-risk pregnancies and to patients and families with inherited cardiovascular disease. Her research interests include pharmacogenomics and implementation of accessible genomic educational materials. Her clinical and research work are deeply rooted in providing equitable and ethical care to patients and participants of California's Central Valley.